News in brief
19-Jan-2017 - Cipla has launched a breath activated inhaler in South Africa.
News in brief
- Cipla targets South African asthma market with breath activated inhaler
- Claris to sell injectable drug business and facilities to Baxter
- Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment
- Amgen secures a wearable injector deal with Unilife
- MannKind ups Afrezza production but Sanofi says sales are modest
16-Jan-2017 - MannKind Corporation met with the US FDA last month to discuss a single-use disposable epinephrine inhaler it says could be an affordable alternative to the Epipen.
11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.
10-Jan-2017 - Quotient Clinical has been hired to develop child-friendly formulations of several off-patent drugs by Proveca Ltd.
09-Jan-2017 - Aurobindo Pharma Limited has agreed to buy Portugal-based Generis Farmaceutica SA for €135m in a deal that includes a tablet and capsule plant in Amadora.
05-Jan-2017 - Shire has sold its MRT messenger RNA platform to RaNA Therapeutics but will retain an equity stake in the Cambridge, Massachusetts-based biotech.
04-Jan-2017 - The Gates Foundation has invested $140m in Intarcia Therapeutics Inc to develop the biotech’s needle-free delivery pump for use with an HIV prophylactic therapy.
04-Jan-2017 - The project funded by the UK and Mexican governments will look to prove the scalability of Prokarium’s oral vaccine platform, the firm says.
Drug Delivery: Featured news
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.